Glycopyrrolate Injection
Product Images NDC 71872-7179

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 71872-7179). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medical Purchasing Solutions, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

71872-7179-1 Pdp (71872 7179 1)

Label for Glycopyrrolate Injection, USP 4 mg/20 mL (0.2 mg/mL) multiple-dose vial. The label includes administration route instructions for intramuscular or intravenous use, preservative benzyl alcohol content 0.9%, storage temperature 20° to 25°C (68° to 77°F), and warnings including not for use in newborns and keep out of reach of children. Distributed by Sandoz Inc. and repackaged by Medical Purchasing Solutions, LLC, Scottsdale, AZ.*

FDA Label Image

Chemical-structure (Glycopyrrolate Injection 01)

Chemical structure of glycopyrrolate, showing its molecular arrangement including aromatic rings, ester groups, and a positively charged nitrogen with a bromide counterion.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.